{"schema_version":"secwatch.filing_event.v1","accession":"0000926326-22-000031","form_type":"8-K","ticker":"OMCL","cik":"0000926326","company_name":"OMNICELL, INC.","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.075038+00:00","generated_at":"2026-06-22T16:39:27.081673+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Omnicell Q3 revenue $348M (+17% YoY); GAAP EPS $0.37; guides Q4 revenue $285M-$295M","bullets":["GAAP net income $17M ($0.37/diluted share) vs $29M ($0.61) in Q3 2021.","Non-GAAP net income $45M ($1.00/diluted share) vs $50M ($1.08) YoY.","FY 2022 revenue guidance lowered to $1.284B-$1.294B; non-GAAP EPS $2.73-$2.83.","Q4 revenue forecast $285M-$295M, down sharply from Q3's $348M.","Cites health system capital freezes and labor shortages as headwinds; plans cost structure adjustments."],"urls":{"canonical":"https://secwatch.observer/filing/0000926326-22-000031","json":"https://secwatch.observer/filing/0000926326-22-000031.json","markdown":"https://secwatch.observer/filing/0000926326-22-000031.md","text":"https://secwatch.observer/filing/0000926326-22-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926326/000092632622000031/0000926326-22-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926326/000092632622000031/omcl-20221102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T16:39:27.081673+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"019e5daf2cb08cad675a2014f57ca2dc5c844b13","claim":"OMNICELL, INC. reported third quarter ended September 30, 2022 results: revenue $348 million, net income $17 million, or $0.37 per diluted share, EPS $1.00 per diluted share. Guidance lowered.","evidence_excerpt":"Omnicell Announces Financial Results for Third Quarter 2022 GAAP and non-GAAP revenues of $348 million GAAP net income per diluted share of $0.37 Non-GAAP net income per diluted share of $1.00","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926326/000092632622000031/0000926326-22-000031-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$348 million"},{"label":"Net income","value":"$17 million, or $0.37 per diluted share"},{"label":"EPS","value":"$1.00 per diluted share"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}